Todd Foley, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 300 shares at $25.04 ($8K) on 2020-06-26, disclosed to the SEC on 2020-06-30.
Scheduled sale ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |